Acute Pancreatitis Targets (APT) Study

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2023

Conditions
Pancreatitis, Acute
Interventions
OTHER

LiDCO

"We plan to elucidate the pathophysiology and molecular subtypes of acute pancreatitis in order to develop specific biomarkers and identify new drug targets. The evaluation will include an analysis of the impact of obesity and the metabolic profile during the disease course of acute pancreatitis.~Supportive treatments will be registered including an assessment of the fluid balance based on the fluid intake and loss and weight. Bioimpedance will be assessed at admission/day1, day 2, day 3,"

Trial Locations (1)

2650

Gastroenheden, Hvidovre Hospital, Hvidovre

All Listed Sponsors
lead

Copenhagen University Hospital, Hvidovre

OTHER

NCT04570852 - Acute Pancreatitis Targets (APT) Study | Biotech Hunter | Biotech Hunter